IP Library › Granted Patent US 9,289,196
Granted Patent B2
US 9,289,196 · App. 11/954,352 · Granted Mar 22, 2016

Hemostatic substance with a coating

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,289,196
App. No.
11/954,352
Granted
Mar 22, 2016
Kind
B2
Abstract

A hemostatic device includes a dissolvable coating and a hemostatic substance enclosed within the coating. The device can have, for example, a generally spherical shape. The hemostatic substance can be particles that take any shape, such as spherical, flat sheets, cubes, or other regular or irregular shapes of any size or volume that can be used on or within a body.

Claims (14)

1. A hemostatic device comprising:

an outer coating that dissolves over a period of time, the outer coating surrounding an interior volume, the interior volume being free of material of the coating; and

a plurality of hemostatic particles disposed inside the interior volume of the outer coating, hemostasis occurring when the hemostatic particles contact blood or blood components after being released by the outer coating upon a sufficient dissolution of the outer coating;

the outer coating being dimensioned to free the entire plurality of hemostatic particles simultaneously at a predetermined time for being released and sized to fit one of a blood vessel, a body cavity, and a vascular prosthesis.

2. The device of claim 1 wherein the device is generally spherical.

3. The device of claim 1 wherein the particles are generally spherical.

4. The device of claim 1 wherein the hemostatic particles include a hemostatic lipid.

5. The device of claim 1 wherein the hemostatic particles include a synthetic.

6. The device of claim 1 wherein the hemostatic particles further include a calcium salt.

7. The device of claim 1 wherein the hemostatic particles include one or more drugs that are released when the coating dissolves.

8. The device of claim 1 wherein the coating is bioabsorbable.

9. The device of claim 8 wherein the coating is a bioabsorbable polymer.

10. The device of claim 1 wherein the hemostatic particles include thrombin.

11. The device of claim 1 wherein the period of time is predetermined to allow time for the hemostatic particles to reach a particular destination within the body before the coating releases the plurality of particles.

Assignments (1)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →